| Literature DB >> 31908801 |
Allison Phad1, Shelly Johnston1, Rachel G Tabak2, Stephanie Mazzucca2, Debra Haire-Joshu3,4.
Abstract
Introduction: The goal of diabetes translation research is to advance research into practice and ensure equitable benefit from scientific evidence. This study uses concept mapping to inform and refine future directions of diabetes translation research with the goal of achieving health equity in diabetes prevention and control. Research design and methods: This study used concept mapping and input from a national network of diabetes researchers and public health practitioners. Concept mapping is a mixed-method, participant-based process. First, participants generated statements by responding to a focus prompt ("To eliminate disparities and achieve health equity in the prevention and treatment of diabetes, research should…"). Participants then sorted statements by conceptual similarity and rated each statement on importance and feasibility (Likert scale of 1-5). A cluster map was created using multidimensional scaling and hierarchical cluster analysis; statements were plotted by average importance and feasibility.Entities:
Keywords: health disparities; translation research
Mesh:
Year: 2019 PMID: 31908801 PMCID: PMC6936412 DOI: 10.1136/bmjdrc-2019-000851
Source DB: PubMed Journal: BMJ Open Diabetes Res Care ISSN: 2052-4897
Sorting and rating participant characteristics
| All sorting and rating participants, | Sorting participants, | Rating participants, | |
| Profession | |||
| Academia | 24 (83) | 20 (80) | 22 (85) |
| Healthcare | 2 (7) | 2 (8) | 2 (8) |
| Public health practitioners | 3 (10) | 3 (12) | 2 (8) |
| Years of experience | |||
| ≤10 years | 7 (24) | 6 (24) | 6 (23) |
| >10 years | 22 (76) | 19 (76) | 20 (77) |
| Race/ethnicity | |||
| American Indian or Alaska Native | 1 (3) | 1 (4) | 1 (4) |
| Asian or Pacific Islander | 0 (0) | 0 (0) | 0 (0) |
| Black or African American | 3 (10) | 2 (8) | 3 (12) |
| Hispanic or Latino(a) | 2 (7) | 1 (4) | 2 (8) |
| White, Hispanic/Latino(a) | 1 (3) | 1 (4) | 1 (4) |
| White, non-Hispanic/Latino(a) | 22 (76) | 20 (80) | 19 (73) |
| WU-CDTR member | 24 (83) | 20 (80) | 22 (85) |
WU-CDTR, The Washington University Center for Diabetes Translation Research.
Figure 1Cluster map of strategies to achieve health equity in diabetes research.
Statements with above average importance rating* by cluster
| Statements by cluster | Average rating | Priority quadrant† | |
| Importance | Feasibility | ||
|
|
|
| |
| Conduct more community-engaged research addressing social context of diabetes prevention | 4.17 | 3.82 | I |
| Engage members of communities with high disease burden in the design and implementation of prevention and treatment solutions | 4.28 | 3.73 | I |
| Engage community stakeholders and residents using a community-engaged research process to identify critical areas | 4.18 | 3.90 | I |
| Partner with the community to raise awareness of both the health implications of diabetes and the simplicity of treatment | 4.00 | 3.91 | I |
| Include the patient population so they are equal partners in research, clinical care, outreach and long-term care | 4.00 | 3.77 | I |
| Be available to tribes when studies are done in their communities | 4.26 | 3.83 | I |
| Incorporate pre-existing community programs that have had success | 4.38 | 4.04 | I |
| Work with local communities and tribes to understand and restore/develop local and indigenous food systems that are responsive to climate change | 3.94 | 2.86 | II |
|
|
|
| |
| Engage clinics and the social service sector | 4.06 | 3.86 | I |
| Develop provider and researcher capacity for conducting community-engaged research and addressing social determinants | 4.00 | 3.65 | I |
| Ensure clear action steps to allow individuals and communities to benefit from research | 3.94 | 3.68 | I |
| Disseminate research findings to make leaders and members of society more aware of the societal costs of poor health access | 4.06 | 3.86 | I |
| Recruit and retain diverse physicians and researchers with experience working with communities impacted by diabetes | 4.38 | 3.60 | II |
|
|
|
| |
| Understand and implement strategies that are adapted to or tailored for communities that experience health disparities | 4.57 | 3.84 | I |
| Understand the diversity of individuals at risk for diabetes and their experiences and perspectives | 4.10 | 4.14 | I |
| Create programs tailored to individual tribal communities | 4.17 | 3.64 | II |
| Build capacity and increase resources within communities of color | 4.29 | 3.38 | II |
| Focus on rural populations to build strategies that are sustainable/accessible in those settings | 4.00 | 3.59 | II |
| Focus on reservation communities to build strategies that are sustainable and accessible in those settings | 4.00 | 3.50 | II |
|
|
|
| |
| Address diabetes prevention among young adults who are disproportionately at risk | 4.00 | 3.88 | I |
| Develop interventions and implementation strategies with vulnerable populations in mind | 4.22 | 4.15 | I |
| Assess whether commonly accepted treatments are having a positive effect on underrepresented populations | 3.94 | 3.82 | I |
| Address comorbidity with behavioral and mental health, especially in the context of low resources and limited access to care | 4.12 | 3.33 | II |
| Focus more on the unique social determinants in diverse communities | 4.22 | 3.48 | II |
|
|
|
| |
| Make sure data are reported by subgroups so comparisons can be made across research projects | 3.94 | 4.00 | I |
| Focus on dissemination and implementation of culturally tailored diabetes prevention programs | 4.17 | 4.14 | I |
| Adopt a multidisciplinary approach | 4.52 | 4.24 | I |
| Focus on providing preventative healthcare | 4.25 | 3.75 | I |
| Address meaningful access to diabetes education, nutritionists, and so on (ie, more than just a referral once at diagnosis from a physician) | 4.06 | 3.55 | II |
|
|
|
| |
| Examine strategies to support patients between clinic appointments to achieve treatment goals | 4.00 | 4.05 | I |
|
|
|
| |
| Emphasize dissemination and implementation of evidence-based treatments and programs | 4.18 | 4.18 | I |
| Study and measure the costs required to continue an effective intervention for longer than 24 months | 4.00 | 3.48 | II |
|
|
|
| |
| Design studies to include implementation outcomes | 4.00 | 4.36 | I |
| Include outcome measures around disparities | 4.05 | 4.60 | I |
|
|
|
| |
| Disseminate research findings to influence health policy | 4.42 | 4.13 | I |
| Have direct implications on practice, research, and policy | 4.17 | 3.43 | II |
| Focus on societal/policy changes that can impact diabetes risk | 4.22 | 3.19 | II |
| Inform an overhaul of the US healthcare system to provide affordable, transparent, trustworthy, and high quality access to all people | 4.24 | 2.05 | II |
| Map the policy context that perpetuate disparities and incorporate into planning for interventions | 3.94 | 3.52 | II |
| Find a way to reduce costs, especially for medication | 4.00 | 2.60 | II |
| Fund more research that budgets for implementation that is in line with real-world costs for future implementation | 4.17 | 3.36 | II |
|
|
|
| |
| Take into account comorbidity and overall care of individuals with multiple, complex diagnoses, conditions | 3.94 | 4.00 | I |
| Incorporate the broader contributors to unhealthy behaviors and lifestyles and work to address these in unison with clinical approaches | 4.06 | 3.62 | II |
| Address root causes at patient and provider levels | 4.06 | 2.71 | II |
| Study the effectiveness of simple, inexpensive, scalable interventions to influence health behaviors, particularly among medically underserved or populations with low socioeconomic status | 4.22 | 3.63 | II |
| Identify affordable healthy living strategies for the poor and working population | 4.11 | 3.29 | II |
| Find ways to address the social determinants of diabetes and related health disparities | 4.24 | 3.43 | II |
| Understand better the pathways by which socioeconomic status disparities drive diabetes | 4.06 | 3.50 | II |
Bold values indicate cluster-level average ratings.
*Mean importance rating=3.91.
†Priority quadrant I characterized by importance≥3.91, feasibility≥3.65, quadrant II characterized by importance≥3.91, feasibility ≤3.65.
Figure 2Cluster pattern match by importance and feasibility.
Figure 3Priority quadrants: statements plotted by average importance and feasibility. Priority quadrants are delineated by above or below average rating for importance (3.91) and feasibility (3.65). Quadrants include: (I) high importance/high feasibility (go-zone); (II) high importance/low feasibility (innovative-targets); (III) low importance/high feasibility and (IV) low importance/low feasibility.